CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase 2 trial of olapari...

by Jung-Min eLee, Jane B. Trepel, Peter eChoyke, Liang eCao, Tristan M Sissung, Nicole eHouston, Minshu eYu, William D Figg, Ismail eTurkbey, Seth M. Steinberg, Min-Jung eLee, Percy eIvy, Joyce eLiu, Ursula eMatulonis, Elise eKohn
Published 2015-06-01